Literature DB >> 10530516

Immunoreactive Akt, PI3-K and ERK protein kinase expression in ischemic rat brain.

H Kitagawa1, H Warita, C Sasaki, W R Zhang, K Sakai, Y Shiro, Y Mitsumoto, T Mori, K Abe.   

Abstract

In order to clarify the role of protein kinases in ischemic brain injury, the spatiotemporal expression of immunoreactive serine-threonine kinase Akt, phosphatidylinositol 3-kinase (PI3-K) and extracellular signal-regulated kinase (ERK) were examined at 3, 8, or 24 h after permanent middle cerebral artery occlusion (MCAO) in rats. Weak staining for these protein kinases was found in both cortical and caudate neurons in sham controls. The staining for Akt-1 and PI3-K was increased at 3-8 h in the ischemic penumbral region and declined at 24 h. A slight induction of these kinases was observed in the ischemic core region. Robust expression of ERK was noted at 3-8 h in most neurons in the area of ischemia. At 24 h, ERK continued to be expressed in the ischemic penumbra, but decreased in the ischemic core. These findings suggest that the signaling for Akt and PI3-K are different from the ERK dependent signal transduction during ischemic brain injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530516     DOI: 10.1016/s0304-3940(99)00676-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

1.  The protective effect of epoxyeicosatrienoic acids on cerebral ischemia/reperfusion injury is associated with PI3K/Akt pathway and ATP-sensitive potassium channels.

Authors:  You-Yang Qu; Mei-Yan Yuan; Yu Liu; Xing-Jun Xiao; Yu-Lan Zhu
Journal:  Neurochem Res       Date:  2014-11-04       Impact factor: 3.996

2.  Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats.

Authors:  Erik A Johnson; Stanislav I Svetlov; Kevin K W Wang; Ronald L Hayes; Jose A Pineda
Journal:  Exp Brain Res       Date:  2005-10-29       Impact factor: 1.972

Review 3.  Neuroprotection against surgically induced brain injury.

Authors:  Vikram Jadhav; Ihsan Solaroglu; Andre Obenaus; John H Zhang
Journal:  Surg Neurol       Date:  2007-01

4.  BAG-1L Protects SH-SY5Y Neuroblastoma Cells Against Hypoxia/Re-oxygenation Through Up-Regulating HSP70 and Activating PI3K/AKT Signaling Pathway.

Authors:  Yun Wang; Chao Jia; Qing-Shu Li; Chun-Yu Xie; Nan Zhang; Yan Qu
Journal:  Neurochem Res       Date:  2017-05-18       Impact factor: 3.996

5.  Early Activation of Phosphatidylinositol 3-Kinase after Ischemic Stroke Reduces Infarct Volume and Improves Long-Term Behavior.

Authors:  Young Seo Kim; Arum Yoo; Jeong Woo Son; Hyun Young Kim; Young-Jun Lee; Sejin Hwang; Kyu-Yong Lee; Young Joo Lee; Cenk Ayata; Hyung-Hwan Kim; Seong-Ho Koh
Journal:  Mol Neurobiol       Date:  2016-09-02       Impact factor: 5.590

6.  Gender-specific response to isoflurane preconditioning in focal cerebral ischemia.

Authors:  Hideto Kitano; Jennifer M Young; Jian Cheng; Lan Wang; Patricia D Hurn; Stephanie J Murphy
Journal:  J Cereb Blood Flow Metab       Date:  2007-01-31       Impact factor: 6.200

Review 7.  Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke.

Authors:  Heng Zhao; Robert M Sapolsky; Gary K Steinberg
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

8.  Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia.

Authors:  K L Jin; X O Mao; D A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 9.  Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration.

Authors:  Suzan Dziennis; Nabil J Alkayed
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

10.  ATP induces mild hypothermia in rats but has a strikingly detrimental impact on focal cerebral ischemia.

Authors:  Meijuan Zhang; Wenjin Li; Guangming Niu; Rehana K Leak; Jun Chen; Feng Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.